Lincoln Pharmaceuticals sets Sept. 30, 2026 as AGM record date; book closure runs Sept. 12–30
AI Market Summary
Lincoln Pharmaceuticals set September 30, 2026 as the AGM record date and outlined book closure (Sep 12–Sep 30) for dividend eligibility, alongside proposing a final dividend of ₹1.80/share. The company also reported strong Q1FY27 results with higher revenue, EBITDA, and net profit, indicating operating leverage. As this is a single-company corporate action and earnings update, broader cross-asset market impact appears limited.
Impact level
● Low
Affected assets
NCCOGOLD2USD/USDT-2.85%
AI Insight · NCCOGOLD2USD/USDTAI Insight
● Neutral
Trade now
⚠️ AI-generated insights are based on news content and are provided for informational purposes only. They do not constitute investment advice or represent the views of BingX. Investing involves risk. Please trade responsibly.
Lincoln Pharmaceuticals set Sept. 30, 2026 as the record date for its 32nd annual general meeting, with the share transfer books to remain closed from Sept. 12 to Sept. 30. The company proposed a final dividend of 1.80 rupees per share of face value 10 rupees, equivalent to an 18% payout. For the quarter ended June 30, 2026, it reported consolidated net profit rising 30.90% year-on-year to 36.23 crore rupees, while total income increased 19.02% to 201.55 crore rupees. EBITDA for the quarter grew 32.29% to 51.70 crore rupees.
